Literature DB >> 26647750

Kinesio Taping® is not better than placebo in reducing pain and disability in patients with chronic non-specific low back pain: a randomized controlled trial.

Maurício A Luz Júnior1, Manoel V Sousa2, Luciana A F S Neves2, Aline A C Cezar2, Leonardo O P Costa3.   

Abstract

BACKGROUND: Kinesio Taping® has been widely used in clinical practice. However, it is unknown whether this type of tape is more effective than placebo taping in patients with chronic lower back pain.
OBJECTIVE: To compare the effectiveness of Kinesio Taping® in patients with chronic non-specific low back pain against a placebo tape and a control group.
METHOD: This is a 3-arm, randomized controlled trial with a blinded assessor. Sixty patients with chronic non-specific low back pain were randomized into one of the three groups: Kinesio Taping® group (n=20), Micropore® (placebo) group (n=20) and control group (n=20). Patients allocated to both the Kinesio Taping® group and the placebo group used the different types of tape for a period of 48 hours. The control group did not receive any intervention. The outcomes measured were pain intensity (measured by an 11-point numerical rating scale) and disability (measured by the 24-item Roland Morris Disability Questionnaire). A blinded assessor measured the outcomes at baseline, 48 hours and 7 days after randomization.
RESULTS: After 48 hours, there was a statistically significant difference between the Kinesio Taping® group versus the control group (mean between-group difference = -3.1 points, 95% CI=-5.2 to -1.1, p=0.003), but no difference when compared to the placebo group (mean between-group difference= 1.9 points, 95% CI=-0.2 to 3.9, p=0.08). For the other outcomes no differences were observed.
CONCLUSIONS: The Kinesio Taping® is not better than placebo (Micropore®) in patients with chronic low back pain.

Entities:  

Mesh:

Year:  2015        PMID: 26647750      PMCID: PMC4668342          DOI: 10.1590/bjpt-rbf.2014.0128

Source DB:  PubMed          Journal:  Braz J Phys Ther        ISSN: 1413-3555            Impact factor:   3.377


Introduction

Low back pain is a serious worldwide health problem1 , 2 and has been quoted as the major cause of disability around the world3 , 4. In Brazil, spinal pain (cervical, thoracic and lumbar) was considered the second most prevalent complaint, affecting approximately 13.5% of the population5. It is estimated that globally 39% of the population will have at least one episode of back pain throughout their lives6. In episodes of pain greater than 12 weeks (classified as chronic lower back pain2), the prognosis is unfavorable2 and is highly associated with high treatment costs and work absenteeism7. A technique widely used today to assist in the treatment of various musculoskeletal conditions is an elastic tape, called Kinesio Taping ®2,8,9. The technique was developed in the 1970s in Japan by Kase et al.10 and consists of tape applied to the skin. This tape has elasticity in the longitudinal direction with an elongation of 40% to 60% from its resting length10. The effects of the Kinesio Taping ® described by its creators included: changes in muscle activation, reduction of pain, joint repositioning and reduction of abnormal muscular tension10 , 11. The use of this technique is widespread in the sports area12 , 13 and is also common in clinical practice14. In the 2008 Olympics, kilometers of Kinesio Taping ® tapes were donated to the delegations of 58 countries, increasing its exposure and curiosity in the use of the tape13 , 15. At the 2012 Olympics, it was noted that the technique had been used by more than 80 delegations12. In recent years, an increasing number of studies using Kinesio Taping ® for pain relief have been conducted16 - 20; however only three of them used the Kinesio Taping ® in the treatment of non-specific chronic lower back pain16 , 17 , 19. Parreira et al.16 compared two forms of application of this tape. One group of patients received the tape as described in the official manual of Kinesio Taping ® Association International21, with tension between 10-15%, generating circumvolutions which are winding movements of the tape around a body part, and in a second group, the tape was applied without any tension to avoid circumvolutions. The authors found no significant difference between groups, which raises the question about the need of circumvolutions when applying the tape. Castro Sánchez et al.17compared the Kinesio Taping ® with a placebo group and the results showed that, although statistically significant for the pain and disability outcomes, the effects were so small that authors did not considered clinically important in relation to the placebo application results. Paoloni et al.19used the Kinesio Taping ® combined with therapeutic exercises. Although the authors observed a decrease in the EMG activity in the paraspinal muscles in patients who underwent the Kinesio Taping ® methods, the results were not statistically significant for the pain when compared to patients who only underwent therapeutic exercises. Studies have been compiled in systematic reviews8 , 13 , 22 - 24 and meta analysis25, and concluded, based on recommendations of the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) from the Cochrane Collaboration26, that there is low quality evidence for the application of Kinesio Taping ® in patients with lower back pain. The term "low quality evidence" means that further studies may or may not eventually alter the conclusions of these reviews26. Therefore, new randomized controlled trials with high methodological quality trials need to be conducted. To date, there is no information on the effects of Kinesio Taping ® due to the lack of studies that compared a group of patients receiving to this intervention versus a control group that did not receive the intervention. Furthermore, in the presence of some beneficial effect, it was unclear whether this effect was due to the intervention or simply due to a placebo effect. Therefore, the aim of this study was to compare the effectiveness of applying Kinesio Taping ®, Micropore® taping (placebo therapy) and a control group with no taping on the outcomes of pain and disability in patients with chronic non-specific low back pain. The observed results were obtained 48 hours and seven days following the application of the different taping methods to the 2 groups for 48 hours. Our hypothesis was that patients who received Kinesio Taping ® would demonstrate greater clinical improvements when compared to patients allocated to the placebo and control groups.

Method

Study design

A three-arm, randomized controlled trial with a blinded assessor was conducted. This study was approved by the Research Ethics Committee of Universidade Paulista (UNIP), São Paulo, SP, Brazil (number 304 408) and prospectively registered at ClinicalTrials.gov (NCT0200766). All patients signed a consent form before the inception of the study.

Study location

The present study was conducted at the Physical Therapy Clinic of UNIP, Campus Jundiaí, SP, Brazil and at private physical therapy clinics in Campo Limpo Paulista City, SP, Brazil, from August to December of 2013.

Subjects

Subjects of both sexes and between 18 and 80 years of age were included. They were referred to physical therapy service by a physician for treatment of chronic non-specific low back pain (back pain of mechanical origin, apparently without a defined cause, for at least 12 weeks duration)27. In addition, participants had not had any physical therapy treatment in the past six months and had never used Kinesio Taping ®. Exclusion criteria were: presence of skin diseases; contraindication due to the use of the tape, serious spinal pathologies such as a tumor, an inflammatory disease or fracture; nerve root compromise; pregnancy; subjects who had physical therapy treatment in the past six months, and subjects who had used or had prior knowledge of the Kinesio Taping ® method. Nerve root compromise was tested through clinical examination involving tests of strength, sensitivity and reflexes following the recommendations of the European Guidelines for the Management of Patients with Back Pain 1.

Randomization and interventions

After the baseline assessment, participants were referred to the physical therapist responsible for the interventions. An independent researcher, who was not involved in the recruitment of the participants, executed a randomization program on a computer to assign each individual to a specific test group. Each participant received a sealed, opaque envelope that revealed their assigned group. The groups were: Kinesio Taping ® Group: the Kinesio ® Tex Classic beige tape was used and applied over the erector spinae muscle with 10-15% of tension in the stretched position, as described in the official manual of Kinesio Taping ® Association International21. Micropore® Group: the Micropore® 3M®tape beige tape was used and applied over the erector spinae muscle in the stretched position. Control Group: this group did not receive any tape intervention. The participants allocated to the Kinesio Taping ® and Micropore® intervention groups received the tape application once and the tape remained in place for 48 hours, following the instructions of the Kinesio Taping ® Association International to minimize the risk of allergies or skin damage. After the application, the subjects were instructed to remove the tape if they had any allergic reaction due to the tape, and in cases where the tapes became loose and began to fall off, the subjects were instructed to report when the tape fell off or was removed to the evaluators at the next evaluation which was when the tape was supposed to be removed (then the tape was re-applied). The application was performed by a physical therapist who had over nine years of clinical experience in treating patients with lower back pain and had formal training in the application of Kinesio Taping ® (level KT3) of the Kinesio Taping ® Association International). After randomization, instructions about the characteristics and expected effects of the Kinesio Taping ®, such as pain relief, were given to the Kinesio Taping ® and Micropore® groups. During the application of the tapes to the groups receiving intervention, subjects were positioned backwards to the physical therapist applying the tape and the distal part of the tape was attached to the posterior superior iliac spine; subjects were then asked to bend the trunk forward until they were in a comfortable flexed position. The tapes were applied over the erector spinae muscles bilaterally moving upward to the 8ththoracic vertebrae. The therapists took about 1-2 minutes to apply the tapes. The control group did not receive any intervention. All subjects were scheduled to begin the physical therapy treatment at the end of the test period (i.e. 7 days after randomization).

Evaluation and instruments

The evaluations were performed at baseline, 48 hours and seven days after randomization, by a blinded evaluator who was unaware of which group the subjects were allocated to. The initial assessment occurred in the clinic and the 48-hour evaluation was conducted by telephone. The evaluation at seven days, in most cases, was carried out in the clinic when the patient returned to start the conventional physical therapy treatment. If the patient missed the day to start the conventional treatment, the evaluation was also conducted by telephone. It was impossible to blind the therapist to the different tapes applied. Furthermore, due to the presence of a group with no taping, the subjects were not blinded to the treatment they received. The outcomes measured were pain intensity and disability. Pain intensity was evaluated using a pain numeric rating scale28, consisting of 11 items, with 0 being "no pain" and 10 the "worst possible pain". Disability was assessed using the Brazilian version of the Roland Morris Disability Questionnaire (RMDQ)29, which contains 24 items related to daily activities that might be impaired due to low back pain where each affirmative answer corresponds to a point on the scale. The final score of the RMDQ was determined by summation of the values obtained: the higher the score, the greater the disability. These scales were cross culturally adapted and tested for the Brazilian Portuguese language30 , 31.

Statistical analysis

The study was designed to detect a clinically important difference for the outcomes of pain and disability32. For pain intensity, a difference of two points was calculated, as measured by the Portuguese version of the Numerical Pain Rating Scale (with a standard deviation estimated at 2.05 points), and three points for disability assessed by Roland Morris Disability Questionnaire29 (with a standard deviation estimated at 5.1 points). A α=0.05, a statistical power of 80% and a sample loss of 15% were considered. The sample size calculation resulted in a sample of 20 participants per group, totaling 60 subjects. A double entry of data was performed, and the analysis followed the principles of intention to treat. Data normality was tested by visual inspection of the histograms, and all data were normally distributed. The confidence interval was set to 95% for all analyses. Estimates of average effects (i.e. between-group differences) for all outcomes were calculated using linear mixed models. These longitudinal models of analyses incorporate terms for treatment groups (Kinesio Taping ®, placebo and control), time (baseline, 48 hours, and seven days post-randomization), and interactions terms of group versus time. The regression coefficients from the interaction group versus time were equivalent to the estimates of the between group differences of the effects of interventions. The post-hoc analyses for multiple comparisons were performed. Data were analyzed using the SPSS 19 for Windows software.

Results

The recruitment of the subjects from the physical therapy clinics was conducted between August and December of 2013. Eighty-three patients with chronic low back pain were enrolled; of these, 23 were excluded because they did not meet the eligibility criteria. Eight patients declined to participate, nine had previously undergone back surgery, five were excluded because of nerve root compromise and one was excluded due to the presence of psoriasis (Figure 1).
Figure 1

Flow diagram of participants throughout the study.

This study included 60 participants with chronic non-specific low back pain, randomly allocated into three groups; a Kinesio Taping ® group (11 women and nine men, mean age of 44.3 years, SD=15.0); a Micropore® group (13 women and seven men, mean age of 50.1 years, SD=17.5); and a control group (17 women and three men, mean age of 48.1 years, SD=13.4). The demographic characteristics of the sample are shown in Table 1.
Table 1.

Baseline characteristics of subjects with chronic low back pain who received Kinesio Taping, micropore taping or had no intervention.

Variable Participants
Kinesio Taping® (n=20) Micropore® Taping (n=20) Control (n=20)
Age (y)44.3 (15.0)50.1 (17.5)48.1 (13.4)
Gender
Male9 (45)7 (35)3 (15)
Female11 (55)13 (65)17 (85)
Duration of low back pain (mo)*76.4 (61.6)49.6 (42.4)82.2 (63.4)
Weight (kg)72.5 (7.1)74.9 (15.7)79.7 (20.9)
Height (m)1.67 (0.1)1.66 (0.1)1.65 (0.1)
Body mass index (kg/m2)26.0 (3.0)27.1 (4.7)30.3 (7.4)
Marital status
Single2 (10)3 (15)1 (5)
Married16 (80)13 (65)18 (90)
Divorced2 (10)1 (5)1 (5)
Widower0 (0)3 (15)0 (0)
Academic level
Primary education10 (50)10 (50)13 (65)
Secondary education6 (30)6 (30)4 (20)
Academic education3 (15)4 (20)3 (15)
MBA1 (5)0 (0)0 (0)
Income (in minimum wages)3.3 (2.4)3.6 (3.1)3.1 (2.2)
Physical therapy treatment
Yes11 (55)11 (55)9 (45)
Use of medication
Yes9 (45)6 (30)5 (25)
Pain intensity (0-10)6.6 (1.2)6.7 (1.6)6.1 (2.1)
Disability (0-24)12.9 (5.6)12.2 (6.5)11.8 (6.5)

The categorical variables are expressed as n (%), and the continuous variables are expressed as mean (SD). *Expressed as median (IQR).

The categorical variables are expressed as n (%), and the continuous variables are expressed as mean (SD). *Expressed as median (IQR). Regarding the use of medications, in the Kinesio Taping ® group nine patients were taking medication as follows: four were taking painkillers, three were taking muscle relaxants and two were taking anti inflammatory drugs. In the Micropore® group, six patients were using medication as follows: one patient was taking analgesics, three were taking muscle relaxants and two were taking anti-inflammatory drugs. In the control group, five patients were using medication as follows: two were taking painkillers, one was taking a muscle relaxant and two were taking anti-inflammatory drugs. From the Kinesio Taping ® group, two participants (10%) abandoned the study and missed the evaluation phases of 48 hours and seven days. From the Micropore® group, one participant (5%) abandoned the study and missed the 48-hour and seven days evaluation. From the control group, none of the participants abandoned the study. Table 2 shows the mean and standard deviation of the pain intensity28 and disability29. Table 3 shows the between-group analysis for all comparisons. A statistically significant difference was observed between the Kinesio Taping ® group and control group for the disability outcome (mean difference of -3.1 points; 95% CI=-5.2 to -1.1) at the 48-hour follow up. No differences were detected between the Kinesio Taping ® and placebo groups for all the outcomes analyzed.
Table 2.

Means (SD) at baseline and 48 hours and seven-day follow-ups for subjects with chronic low back pain who received Kinesio Taping, Micropore taping or had no intervention.

Outcome Interventions
Baseline Follow-up 48 hours Follow-up 7 days
Kinesio Taping® Group Micropore® Taping Group Control Group Kinesio Taping® Micropore® Taping Group Control Group Kinesio Taping® Micropore® Taping Group Control Group
Pain6.66.7 6.14.95.15.45.86.35.5
(0-10)(1.2) (1.6) (2.1) (2.6)(2.7)(2.6)(1.3) (2.0)(1.9)
Disability 12.812.2 11.88.69.410.69.610.210.3
(0-24)(5.6) (6.5)(6.5) (5.6)(6.7)(6.9)(5.6) (7.4)(6.6)

Data expressed as mean and standard deviation (SD).

Table 3.

Between-group differences at 48 hours and 7-days after randomization for subjects with chronic low back pain who received Kinesio Taping, Micropore taping or had no intervention.

Outcome Difference between interventions Adjusted Mean Difference (95% CI)
Baseline to Follow-up at 48 hours (95% CI), p Baseline to Follow-up at 7 days (95% CI), p
Kinesio vs Micropore p Kinesio vs Control p Micropore vs Control p Kinesio vs Micropore p Kinesio vs Control p Micropore vs Control p
Pain 0.1 0.82-1.00.09-0.80.130.30.54-0.2 0.760.2 0.75
(0-10)(-1.0 to 1.2) (-2.1 to 0.1) (-1.9 to 0.3) (-0.8 to 1.5)(-1.3 to 0.9)(-0-9 to 1.3)
Disability 1.9 0.08-3.1*0.003-1.3 0.221.7 0.11-1.80.08-0.1 0.89
(0-24)(-0.2 to 3.9) (-5.2 to -1.1)(-3.3 to 0.8)(-0.4 to 3.8) (-3.9 to 0.2)(-2.2 to 1.9)

*Significant difference (p<0.05).

Data expressed as mean and standard deviation (SD). *Significant difference (p<0.05).

Discussion

This study tested the effects of a single application of Kinesio Taping ® compared with Micropore® (placebo group) taping and a control group with no intervention in patients with chronic non-specific low back pain for the outcomes of pain intensity and disability. This is the first study that compared the Kinesio Taping ® method with Micropore® taping as a form of placebo therapy. The authors observed that, although the Kinesio Taping ® group showed an improved disability score 48 hours after the application of the tape, the observed difference is so small that it could not be considered clinically important. All other statistical comparisons between groups showed no statistical significance. These findings raise a question regarding the use of Kinesio Taping ® in clinical practice for patients with chronic non-specific low back pain since the effects observed (small) appears to be due to the placebo effect, regression to the mean, natural history and other possible confounders. One of the strengths of this study is related to the recruitment of subjects. It has been shown that studies which recruited subjects seeking treatment for low back pain get more representative results than studies which recruited subjects from the community33. The limitations of our study included the fact that clinician were not blinded to the allocation of the participants to the groups - this was impossible due to the therapist's experience with the use of Kinesio Taping ® - and that some of the seven-day assessments were conducted at the clinic while others were conducted by phone. This criterion was adopted to avoid a sample loss above 15%, which could interfere with the results due to attrition bias. Although the subjects allocated in the Micropore® group were inclined to believe that they were using the Kinesio Taping ® tape, the authors cannot consider this as a blinded study since the participants allocated to the control group received no intervention for the seven days. Participants from the control group were asked to avoid telling the assessor, at the time of the reassessment, whether they had or had not received taping. This allowed for the evaluator to remain blinded during the study. Finally, the authors observed that there was a higher proportion of painkiller users in the Kinesio Taping ® group, which may have influenced the study results. Although all participants showed some improvement (as described in Table 2), these differences could not be considered clinically important since none of these differences were greater than two points for the pain outcome and five points for the disability outcome, which were the cutoff points considered clinically significant32. When the pain outcome was analyzed between groups, no statistically significant difference was observed. However, this result should be considered with caution, since the effect size was approximately one point when the two groups that received intervention were compared with the control group. When the authors analyzed the Kinesio Taping ® group versus the Micropore® group, this difference was practically nil, which favors the hypothesis that the Kinesio Taping ® is similar to the Micropore® taping in the treatment of patients with chronic non-specific low back pain. In a study19 conducted using Kinesio Taping ® associated with therapeutic exercises, where one group received the taping, a second group received the tape combined with therapeutic exercises, and a third group received only the therapeutic exercises, the results showed no difference among the groups. These results corroborate our study, since there was no statistically significant difference between the groups that received a taping intervention16. In relation to the disability outcome, the difference was only statistically significant different when the Kinesio Taping ® group was compared to the control group after 48 hours. However, the observed difference was too small and could not be considered clinically important. In addition, these differences were not observed at seven days. In another study17 that compared the application of Kinesio Taping ® versus a placebo application the results were favorable for the Kinesio Taping ® group for the outcomes pain and disability. The hypothesis for the difference observed might be related to how the taping was applied. For the Kinesio Taping ® group, four strips with 25% of tension were superimposed, in a star format, to the point of greatest pain, while the placebo group received a single strip without tension in the transverse direction over the greatest point of pain. The difference in placement may have been more comfortable for the subjects that used more strips. These results showed the importance of studies focused on analyzing the different types of tape placement. Studies describing the electromyographic activity of muscles submitted to different tape and tension applications of Kinesio Taping ® should also be encouraged. Although systematic reviews8 , 13 , 22 - 24 do not recommend the use of Kinesio Taping ® in clinical practice, the results of this study suggest that Kinesio Taping ® was superior to no treatment for the disability outcome 48 hours after the application of the tape. For the pain outcome, although no statistically significant differences were found, the effect size was slightly higher in the groups using Kinesio Taping ® and Micropore® taping when compared to the control group. These results raise the hypothesis that subjects who received Kinesio Taping ® or Micropore® taping may remain more active and returned to their normal activities earlier, as it is recommended for patients with back pain34 , 35, than patients who did not receive any form of intervention. However these improvements are due to placebo effects only.

Conclusion

The results showed that Kinesio Taping ® showed similar results to Micropore® taping in the outcomes investigated at 48 hours and at seven days after baseline testing. The Kinesio Taping ® intervention was superior only when compared to the control group for the disability outcome at the 48-hour assessment. Therefore, the results of this study confirm that the therapeutic effects of the Kinesio Taping ® are similar to the placebo effect. These results suggest that physical therapists should avoid this type of therapy.
  30 in total

Review 1.  Kinesio taping for sports injuries.

Authors:  Steven J Kamper; Nicholas Henschke
Journal:  Br J Sports Med       Date:  2013-11       Impact factor: 13.800

Review 2.  Current evidence does not support the use of Kinesio Taping in clinical practice: a systematic review.

Authors:  Patrícia do Carmo Silva Parreira; Lucíola da Cunha Menezes Costa; Luiz Carlos Hespanhol; Alexandre Dias Lopes; Leonardo Oliveira Pena Costa
Journal:  J Physiother       Date:  2014-04-24       Impact factor: 7.000

Review 3.  The clinical effects of Kinesio® Tex taping: A systematic review.

Authors:  D Morris; D Jones; H Ryan; C G Ryan
Journal:  Physiother Theory Pract       Date:  2012-10-22       Impact factor: 2.279

4.  GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength.

Authors:  Jeffrey C Andrews; Holger J Schünemann; Andrew D Oxman; Kevin Pottie; Joerg J Meerpohl; Pablo Alonso Coello; David Rind; Victor M Montori; Juan Pablo Brito; Susan Norris; Mahmoud Elbarbary; Piet Post; Mona Nasser; Vijay Shukla; Roman Jaeschke; Jan Brozek; Ben Djulbegovic; Gordon Guyatt
Journal:  J Clin Epidemiol       Date:  2013-04-06       Impact factor: 6.437

5.  Does Kinesio taping in addition to exercise therapy improve the outcomes in subacromial impingement syndrome? A randomized, double-blind, controlled clinical trial.

Authors:  Hacer Hicran Şimşek; Selvin Balki; Sinem Suner Keklik; Hayati Öztürk; Hasan Elden
Journal:  Acta Orthop Traumatol Turc       Date:  2013       Impact factor: 1.511

6.  Do convolutions in Kinesio Taping matter? Comparison of two Kinesio Taping approaches in patients with chronic non-specific low back pain: protocol of a randomised trial.

Authors:  Patrícia do Carmo Silva Parreira; Luciola da Cunha Menezes Costa; Ricardo Takahashi; Luiz Carlos Hespanhol Junior; Tatiane Motta Silva; Maurício Antônio da Luz Junior; Leonardo Oliveira Pena Costa
Journal:  J Physiother       Date:  2013-03       Impact factor: 7.000

Review 7.  A systematic review of the global prevalence of low back pain.

Authors:  Damian Hoy; Christopher Bain; Gail Williams; Lyn March; Peter Brooks; Fiona Blyth; Anthony Woolf; Theo Vos; Rachelle Buchbinder
Journal:  Arthritis Rheum       Date:  2012-01-09

Review 8.  A systematic review of the effectiveness of kinesio taping for musculoskeletal injury.

Authors:  Mehran Mostafavifar; Jess Wertz; James Borchers
Journal:  Phys Sportsmed       Date:  2012-11       Impact factor: 2.241

9.  The influence of Kinesio Taping on the effects of physiotherapy in patients after laparoscopic cholecystectomy.

Authors:  Marcin Krajczy; Katarzyna Bogacz; Jacek Luniewski; Jan Szczegielniak
Journal:  ScientificWorldJournal       Date:  2012-05-03

10.  Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

Authors:  Theo Vos; Abraham D Flaxman; Mohsen Naghavi; Rafael Lozano; Catherine Michaud; Majid Ezzati; Kenji Shibuya; Joshua A Salomon; Safa Abdalla; Victor Aboyans; Jerry Abraham; Ilana Ackerman; Rakesh Aggarwal; Stephanie Y Ahn; Mohammed K Ali; Miriam Alvarado; H Ross Anderson; Laurie M Anderson; Kathryn G Andrews; Charles Atkinson; Larry M Baddour; Adil N Bahalim; Suzanne Barker-Collo; Lope H Barrero; David H Bartels; Maria-Gloria Basáñez; Amanda Baxter; Michelle L Bell; Emelia J Benjamin; Derrick Bennett; Eduardo Bernabé; Kavi Bhalla; Bishal Bhandari; Boris Bikbov; Aref Bin Abdulhak; Gretchen Birbeck; James A Black; Hannah Blencowe; Jed D Blore; Fiona Blyth; Ian Bolliger; Audrey Bonaventure; Soufiane Boufous; Rupert Bourne; Michel Boussinesq; Tasanee Braithwaite; Carol Brayne; Lisa Bridgett; Simon Brooker; Peter Brooks; Traolach S Brugha; Claire Bryan-Hancock; Chiara Bucello; Rachelle Buchbinder; Geoffrey Buckle; Christine M Budke; Michael Burch; Peter Burney; Roy Burstein; Bianca Calabria; Benjamin Campbell; Charles E Canter; Hélène Carabin; Jonathan Carapetis; Loreto Carmona; Claudia Cella; Fiona Charlson; Honglei Chen; Andrew Tai-Ann Cheng; David Chou; Sumeet S Chugh; Luc E Coffeng; Steven D Colan; Samantha Colquhoun; K Ellicott Colson; John Condon; Myles D Connor; Leslie T Cooper; Matthew Corriere; Monica Cortinovis; Karen Courville de Vaccaro; William Couser; Benjamin C Cowie; Michael H Criqui; Marita Cross; Kaustubh C Dabhadkar; Manu Dahiya; Nabila Dahodwala; James Damsere-Derry; Goodarz Danaei; Adrian Davis; Diego De Leo; Louisa Degenhardt; Robert Dellavalle; Allyne Delossantos; Julie Denenberg; Sarah Derrett; Don C Des Jarlais; Samath D Dharmaratne; Mukesh Dherani; Cesar Diaz-Torne; Helen Dolk; E Ray Dorsey; Tim Driscoll; Herbert Duber; Beth Ebel; Karen Edmond; Alexis Elbaz; Suad Eltahir Ali; Holly Erskine; Patricia J Erwin; Patricia Espindola; Stalin E Ewoigbokhan; Farshad Farzadfar; Valery Feigin; David T Felson; Alize Ferrari; Cleusa P Ferri; Eric M Fèvre; Mariel M Finucane; Seth Flaxman; Louise Flood; Kyle Foreman; Mohammad H Forouzanfar; Francis Gerry R Fowkes; Richard Franklin; Marlene Fransen; Michael K Freeman; Belinda J Gabbe; Sherine E Gabriel; Emmanuela Gakidou; Hammad A Ganatra; Bianca Garcia; Flavio Gaspari; Richard F Gillum; Gerhard Gmel; Richard Gosselin; Rebecca Grainger; Justina Groeger; Francis Guillemin; David Gunnell; Ramyani Gupta; Juanita Haagsma; Holly Hagan; Yara A Halasa; Wayne Hall; Diana Haring; Josep Maria Haro; James E Harrison; Rasmus Havmoeller; Roderick J Hay; Hideki Higashi; Catherine Hill; Bruno Hoen; Howard Hoffman; Peter J Hotez; Damian Hoy; John J Huang; Sydney E Ibeanusi; Kathryn H Jacobsen; Spencer L James; Deborah Jarvis; Rashmi Jasrasaria; Sudha Jayaraman; Nicole Johns; Jost B Jonas; Ganesan Karthikeyan; Nicholas Kassebaum; Norito Kawakami; Andre Keren; Jon-Paul Khoo; Charles H King; Lisa Marie Knowlton; Olive Kobusingye; Adofo Koranteng; Rita Krishnamurthi; Ratilal Lalloo; Laura L Laslett; Tim Lathlean; Janet L Leasher; Yong Yi Lee; James Leigh; Stephen S Lim; Elizabeth Limb; John Kent Lin; Michael Lipnick; Steven E Lipshultz; Wei Liu; Maria Loane; Summer Lockett Ohno; Ronan Lyons; Jixiang Ma; Jacqueline Mabweijano; Michael F MacIntyre; Reza Malekzadeh; Leslie Mallinger; Sivabalan Manivannan; Wagner Marcenes; Lyn March; David J Margolis; Guy B Marks; Robin Marks; Akira Matsumori; Richard Matzopoulos; Bongani M Mayosi; John H McAnulty; Mary M McDermott; Neil McGill; John McGrath; Maria Elena Medina-Mora; Michele Meltzer; George A Mensah; Tony R Merriman; Ana-Claire Meyer; Valeria Miglioli; Matthew Miller; Ted R Miller; Philip B Mitchell; Ana Olga Mocumbi; Terrie E Moffitt; Ali A Mokdad; Lorenzo Monasta; Marcella Montico; Maziar Moradi-Lakeh; Andrew Moran; Lidia Morawska; Rintaro Mori; Michele E Murdoch; Michael K Mwaniki; Kovin Naidoo; M Nathan Nair; Luigi Naldi; K M Venkat Narayan; Paul K Nelson; Robert G Nelson; Michael C Nevitt; Charles R Newton; Sandra Nolte; Paul Norman; Rosana Norman; Martin O'Donnell; Simon O'Hanlon; Casey Olives; Saad B Omer; Katrina Ortblad; Richard Osborne; Doruk Ozgediz; Andrew Page; Bishnu Pahari; Jeyaraj Durai Pandian; Andrea Panozo Rivero; Scott B Patten; Neil Pearce; Rogelio Perez Padilla; Fernando Perez-Ruiz; Norberto Perico; Konrad Pesudovs; David Phillips; Michael R Phillips; Kelsey Pierce; Sébastien Pion; Guilherme V Polanczyk; Suzanne Polinder; C Arden Pope; Svetlana Popova; Esteban Porrini; Farshad Pourmalek; Martin Prince; Rachel L Pullan; Kapa D Ramaiah; Dharani Ranganathan; Homie Razavi; Mathilda Regan; Jürgen T Rehm; David B Rein; Guiseppe Remuzzi; Kathryn Richardson; Frederick P Rivara; Thomas Roberts; Carolyn Robinson; Felipe Rodriguez De Leòn; Luca Ronfani; Robin Room; Lisa C Rosenfeld; Lesley Rushton; Ralph L Sacco; Sukanta Saha; Uchechukwu Sampson; Lidia Sanchez-Riera; Ella Sanman; David C Schwebel; James Graham Scott; Maria Segui-Gomez; Saeid Shahraz; Donald S Shepard; Hwashin Shin; Rupak Shivakoti; David Singh; Gitanjali M Singh; Jasvinder A Singh; Jessica Singleton; David A Sleet; Karen Sliwa; Emma Smith; Jennifer L Smith; Nicolas J C Stapelberg; Andrew Steer; Timothy Steiner; Wilma A Stolk; Lars Jacob Stovner; Christopher Sudfeld; Sana Syed; Giorgio Tamburlini; Mohammad Tavakkoli; Hugh R Taylor; Jennifer A Taylor; William J Taylor; Bernadette Thomas; W Murray Thomson; George D Thurston; Imad M Tleyjeh; Marcello Tonelli; Jeffrey A Towbin; Thomas Truelsen; Miltiadis K Tsilimbaris; Clotilde Ubeda; Eduardo A Undurraga; Marieke J van der Werf; Jim van Os; Monica S Vavilala; N Venketasubramanian; Mengru Wang; Wenzhi Wang; Kerrianne Watt; David J Weatherall; Martin A Weinstock; Robert Weintraub; Marc G Weisskopf; Myrna M Weissman; Richard A White; Harvey Whiteford; Steven T Wiersma; James D Wilkinson; Hywel C Williams; Sean R M Williams; Emma Witt; Frederick Wolfe; Anthony D Woolf; Sarah Wulf; Pon-Hsiu Yeh; Anita K M Zaidi; Zhi-Jie Zheng; David Zonies; Alan D Lopez; Christopher J L Murray; Mohammad A AlMazroa; Ziad A Memish
Journal:  Lancet       Date:  2012-12-15       Impact factor: 79.321

View more
  22 in total

1.  Linfotaping with Kinesio® Tape to manage and treat lymphedema patients: safety and tolerability are more important than efficacy?

Authors:  L F Nevola Teixeira; F Sandrin; F Baggi; M C Simoncini
Journal:  Support Care Cancer       Date:  2016-03-17       Impact factor: 3.603

2.  Comment on "Linfotaping with Kinesio® Tape to manage and treat lymphedema patients: safety and tolerability are more important than efficacy".

Authors:  Taner Dandinoglu; Özgür Dandin; Murat Karadeniz
Journal:  Support Care Cancer       Date:  2016-06-24       Impact factor: 3.603

3.  Efficacy and safety of novel low-intensity pulsed ultrasound (LIPUS) in treating mild to moderate erectile dysfunction: a multicenter, randomized, double-blind, sham-controlled clinical study.

Authors:  Wanshou Cui; Huixi Li; Ruili Guan; Meng Li; Bicheng Yang; Zhanwei Xu; Maofan Lin; Long Tian; Xiaodong Zhang; Bao Li; Weiguang Liu; Zhilong Dong; Zhiping Wang; Tao Zheng; Weixing Zhang; Guiting Lin; Yinglu Guo; Zhongcheng Xin
Journal:  Transl Androl Urol       Date:  2019-08

4.  A novel (targeted) kinesio taping application on chronic low back pain: Randomized clinical trial.

Authors:  María Lourdes Peñalver-Barrios; Juan Francisco Lisón; Javier Ballester-Salvador; Julia Schmitt; Aida Ezzedinne-Angulo; María Dolores Arguisuelas; Julio Doménech
Journal:  PLoS One       Date:  2021-05-13       Impact factor: 3.240

5.  Short-Term Effects of Kinesio Taping in Women with Pregnancy-Related Low Back Pain: A Randomized Controlled Clinical Trial.

Authors:  Şeyhmus Kaplan; Mahmut Alpayci; Erbil Karaman; Orkun Çetin; Yasemin Özkan; Server İlter; Volkan Şah; Hanım Güler Şahin
Journal:  Med Sci Monit       Date:  2016-04-18

6.  Prolonged use of Kinesiotaping does not enhance functional performance and joint proprioception in healthy young males: Randomized controlled trial.

Authors:  Igor Magalhães; Martim Bottaro; João R Freitas; Jake Carmo; João P C Matheus; Rodrigo L Carregaro
Journal:  Braz J Phys Ther       Date:  2016-03-18       Impact factor: 3.377

7.  Effects of underwater ultrasound therapy on pain, inflammation, hand function and quality of life in patients with rheumatoid arthritis - a randomized controlled trial.

Authors:  Márta Király; Zsuzsanna Varga; Ferenc Szanyó; Rita Kiss; Katalin Hodosi; Tamás Bender
Journal:  Braz J Phys Ther       Date:  2017-04-13       Impact factor: 3.377

8.  The effect of Kinesio taping on back pain in patients with Lenke Type 1 adolescent idiopathic scoliosis: A randomized controlled trial.

Authors:  Yunus Atici; Canan Gonen Aydin; Aysegul Atici; Mehmet Ozbey Buyukkuscu; Yavuz Arikan; Mehmet Bulent Balioglu
Journal:  Acta Orthop Traumatol Turc       Date:  2017-03-19       Impact factor: 1.511

9.  Effects of photobiomodulation therapy in patients with chronic non-specific low back pain: protocol for a randomised placebo-controlled trial.

Authors:  Shaiane Silva Tomazoni; Lucíola da Cunha Menezes Costa; Layana de Souza Guimarães; Amanda Costa Araujo; Dafne Port Nascimento; Flávia Cordeiro de Medeiros; Marina Athayde Avanzi; Leonardo Oliveira Pena Costa
Journal:  BMJ Open       Date:  2017-10-24       Impact factor: 2.692

10.  Is Kinesio Taping to Generate Skin Convolutions Effective for Increasing Local Blood Circulation?

Authors:  Jae-Man Yang; Jung-Hoon Lee
Journal:  Med Sci Monit       Date:  2018-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.